Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

3.9K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.9K
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

3.3K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
3.3K
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

648
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
648
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs01:21

Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

790
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
790
Second Order systems II01:18

Second Order systems II

414
In an underdamped second-order system, where the damping ratio ζ is between 0 and 1, a unit-step input results in a transfer function that, when transformed using the inverse Laplace method, reveals the output response. The output exhibits a damped sinusoidal oscillation, and the difference between the input and output is termed the error signal. This error signal also demonstrates damped oscillatory behavior. Eventually, as the system reaches a steady state, the error diminishes to zero.
414
First Order Systems01:21

First Order Systems

438
First-order systems, such as RC circuits, are foundational in understanding dynamic systems due to their straightforward input-output relationship. Analyzing their responses to different input functions under zero initial conditions reveals significant insights into system behavior.
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
438

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

USP Gene Network Modulation and Osmoprotection Define Salt Resilience in Chenopodium quinoa Genotypes.

Scientific reports·2026
Same author

Ondansetron derivatives as potential PTP1B inhibitors for treating type 2 diabetes mellitus: <i>in silico</i>, <i>in vitro</i>, and <i>in vivo</i> analysis.

Frontiers in pharmacology·2026
Same author

Integrated morpho-physiological, metabolomic and transcriptomic profiling uncovers ethylene-mediated metabolic regulation shaping drought resilience in wheat.

BMC plant biology·2026
Same author

Ethylene signaling and metabolite reprogramming in salt tolerance of Triticum aestivum.

Scientific reports·2026
Same author

Corrigendum to "Repurposing of FDA-approved drugs to identify potential NS2B/NS3 protease inhibitors against dengue virus: In silico and in vitro evaluation" [Acta Tropica volume 274 (2026) 107987].

Acta tropica·2026
Same author

Molecular docking of the DREB(A-6) group and enhanced thermotolerance in potato by overexpressing the DREB(A-6) gene.

Journal of plant research·2026
Same journal

Artificial intelligence-driven multi-omics analysis of gut-kidney axis in chronic kidney disease.

Progress in molecular biology and translational science·2026
Same journal

Artificial intelligence in multi-omics analysis of heart diseases.

Progress in molecular biology and translational science·2026
Same journal

AI in multi-omics analysis of type 2 diabetes.

Progress in molecular biology and translational science·2026
Same journal

AI in multi-omics analysis in AMR.

Progress in molecular biology and translational science·2026
Same journal

AI in multi-omics analysis of COVID-19 patient data.

Progress in molecular biology and translational science·2026
Same journal

AI in multi-omics analysis of liver diseases.

Progress in molecular biology and translational science·2026
関連記事をすべて見る

関連する実験動画

Updated: Feb 15, 2026

Rapid Characterization of Genetic Parts with Cell-Free Systems
05:00

Rapid Characterization of Genetic Parts with Cell-Free Systems

Published on: August 30, 2021

2.3K

バイオトランスフォーメーションのためのセルフリーシステム

Huzaifa Ibrahim1, Nimra Arshad1, Hunaiza Fatima2

  • 1Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan.

Progress in molecular biology and translational science
|February 13, 2026
PubMed
まとめ
この要約は機械生成です。

細胞なしの生物変換はバイオテクノロジーを進歩させ,貴重な化学物質と治療薬の効率的な合成を可能にします. 現代の細胞フリータンパク質合成 (CFPS) は,生産性の向上と環境に優しい製造のためのプロセスを最適化します.

キーワード:
生物学的物質は,生物学的物質である.バイオトランスフォーメーションセルフリーシステムは,セルフリーシステムです.メタボロミクスとはタンパク質合成 タンパク質合成

さらに関連する動画

The Use of Chemostats in Microbial Systems Biology
13:19

The Use of Chemostats in Microbial Systems Biology

Published on: October 14, 2013

31.8K
Cell Co-culture Patterning Using Aqueous Two-phase Systems
10:11

Cell Co-culture Patterning Using Aqueous Two-phase Systems

Published on: March 26, 2013

19.5K

関連する実験動画

Last Updated: Feb 15, 2026

Rapid Characterization of Genetic Parts with Cell-Free Systems
05:00

Rapid Characterization of Genetic Parts with Cell-Free Systems

Published on: August 30, 2021

2.3K
The Use of Chemostats in Microbial Systems Biology
13:19

The Use of Chemostats in Microbial Systems Biology

Published on: October 14, 2013

31.8K
Cell Co-culture Patterning Using Aqueous Two-phase Systems
10:11

Cell Co-culture Patterning Using Aqueous Two-phase Systems

Published on: March 26, 2013

19.5K

科学分野:

  • バイオテクノロジー バイオテクノロジー
  • 合成生物学 合成生物学とは
  • バイオケミストリー バイオケミストリー

背景:

  • 細胞フリーシステムは,従来の方法から,現代の細胞フリータンパク質合成 (CFPS) に進化しました.
  • この進化は,生物医学技術者や研究者のための最適化強化を可能にします.
  • バイオトランスフォーメーションは,治療薬,バイオ燃料,化学物質の合成に不可欠です.

研究 の 目的:

  • 従来のセルフリーシステムから現代のCFPSへの移行を紹介する.
  • 主要な生物変換反応と経路最適化戦略を探求する.
  • セルフリーシステムの実用的な応用と将来の方向性を強調する.

主な方法:

  • 酵素触媒,リドックス変換,および水分解プロセスを含む生物変換プロセスのレビュー.
  • モジュール式設計のための経路とプロセスの最適化にフォーカスします.
  • 合成生物学プラットフォームを機械学習と高通量スクリーニングと統合する.

主要な成果:

  • バイオ燃料生成,治療用タンパク質合成,環境に優しい製造における実用的な利点が実証されています.
  • より良い収穫量,適応性,不要な物質の削減を達成しました.
  • 細胞フリーシステムの生物変換の有効性を強調した.

結論:

  • 細胞のないシステムは,将来の生産とバイオ変換の進歩にとって不可欠です.
  • エコフレンドリーな化学,人工細胞,合成生物学的薬品のブレークスルーは,細胞フリー技術によって推進されています.
  • 最適化されたセルフリーシステムは,産業用アプリケーションに効率的で適応可能なソリューションを提供します.